Prevention of late breast cancer (BC) events in postmenopausal women with endocrine responsive BC.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/510787

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This proposal is from Australia's national breast cancer (BC) trials group, the ANZ BCTG, for a new phase III, multi-centre clinical trial evaluating whether much later endocrine therapy with an aromatase inhibitor can prevent BC recurrence in postmenopausal women who have: had hormone sensitive BC at least 6 years ago; were treated by Tamoxifen more than 1 year ago; and, are currently disease free. Subjects will randomly receive letrozole or placebo as a daily tablet for five years.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2015

Funding Scheme: NHMRC Project Grants

Funding Amount: $4,687,599.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology And Carcinogenesis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

breast cancer | disease free | endocrine responsive breast cancer | endocrine therapy | postmenopausal | preventative medicine | randomised clinical trial | recurrence prevention | women's health

Related Links